Lifeboat Foundation

What if the next global health crisis is a mental health pandemic? It is here now.

According to Gallup, anger, stress, worry and sadness have been on the rise globally for the past decade — long before the COVID-19 pandemic — and all reached record highs in 2020.

People die from COVID-19 — they also die from depression and anxiety disorders. The U.S. has seen spikes in deaths from suicide and “deaths of despair.”

Continue reading “The Next Global Pandemic: Mental Health” »

The idea of Web 3.0 has been disappointing for Elon Musk and he has referred to it as BS. The reasons are unclear but might be soon unveiled.

TL;DR Breakdown.

Web 2.0 has ensured that the informational needs are fulfilled and has also opened ways for education, finance, banking, health, and other domains. As all these are integrated into a new space, we have the opportunity to see the evolution of the web.

A silicon device that can change skin tissue into blood vessels and nerve cells has advanced from prototype to standardized fabrication, meaning it can now be made in a consistent, reproducible way. As reported in Nature Protocols, this work, developed by researchers at the Indiana University School of Medicine, takes the device one step closer to potential use as a treatment for people with a variety of health concerns.

The technology, called tissue nanotransfection, is a non-invasive nanochip device that can reprogram tissue function by applying a harmless electric spark to deliver specific genes in a fraction of a second. In laboratory studies, the device successfully converted skin tissue into blood vessels to repair a badly injured leg. The technology is currently being used to reprogram tissue for different kinds of therapies, such as repairing brain damage caused by stroke or preventing and reversing nerve damage caused by diabetes.

Biodiversity conservation, public health and improved livelihoods — dr gladys kalema-zikusoka, founder and CEO, conservation through public health.

Dr. Gladys Kalema-Zikusoka, is the Founder and CEO of Conservation Through Public Health (CTPH — https://ctph.org/), a 16-year old non-profit organization, based in Uganda, that promotes conservation by improving the quality of life of people and wildlife to enable them to coexist in and around protected areas in Africa, and she has become one of the leading conservationists and scientists working to save the critically endangered mountain gorillas of East Africa.

Continue reading “Dr. Gladys Kalema-Zikusoka, Founder and CEO, Conservation Through Public Health (CTPH), Uganda” »

Bridging Technology And Medicine For The Modern Healthcare Ecosystem — Dr. Mona G. Flores, MD, Global Head of Medical AI, NVIDIA.

Dr. Mona Flores M.D., is the Global Head of Medical AI, at NVIDIA (https://blogs.nvidia.com/blog/author/monaflores/), the American multinational technology company, where she oversees the company’s AI initiatives in medicine and healthcare to bridge the chasm between technology and medicine.

Continue reading “Dr. Mona Flores, M.D., Global Head of Medical AI, NVIDIA — Bridging Technology And Medicine” »

U.S. health officials on Wednesday reported the country’s first case of the Omicron variant of the coronavirus, in a person in California.

The Covid-19 case was identified by the California and San Francisco health departments in a person who had traveled to South Africa and returned on Nov. 22, the Centers for Disease Control and Prevention said in a release. The individual, who was fully vaccinated with the Moderna shot but had not received a booster, had mild symptoms and has since recovered, federal and local officials said. The person has been isolating since testing positive on Nov. 29. All close contacts have tested negative thus far.

The discovery of Omicron in the United States is not a surprise. Upon characterizing the mutations in the variant, scientists in South Africa last week quickly raised the world’s alarms about the potential threat it posed, but it had already started to circulate silently. Some two dozen countries, from the United Kingdom to Australia to Israel, have already reported cases, many in travelers.

NASA and the U.S. Dept. of Energy have come together to solicit design proposals for a nuclear reactor that will power Lunar and Martian exploration!

Over the next fifteen years, multiple space agencies and their commercial partners intend to mount crewed missions to the Moon and Mars. In addition to placing “footprints and flags” on these celestial bodies, there are plans to establish the infrastructure to allow for a long-term human presence. To meet these mission requirements and ensure astronaut safety, several technologies are currently being researched and developed.

At their core, these technologies are all about achieving self-sufficiency in terms of resources, materials, and energy. To ensure that these missions have all the energy they need to conduct operations, NASA is developing a Fission Surface Power (FSP) system that will provide a safe, efficient, and reliable electricity supply. In conjunction with solar cells, batteries, and fuel cells, this technology will allow for long-term missions to the Moon and Mars in the near future.

Continue reading “NASA is Building a Nuclear Reactor to Power Lunar and Martian Exploration!” »

The race to find medical treatments for Covid-19—and future pandemics—is on, driving renewed investments by the healthcare and pharmaceutical industries in Real-World Data (RWD) and Real-World Evidence (RWE). A new report on AI and the real-world studies industry, from Deep Pharma Intelligence (DPI), Evomics Medical and The Yuan (an online forum focused on AI in healthcare, for which I am a contributor), provides fresh insights into this rapidly evolving patient-centric approach to increasing R&D efficiency, accelerating the introduction of new drugs, and improving health outcomes. Full Story:

TRU Community Care in Lafayette was the host to the unveiling of a brand new technology in the medical field — a humanoid robot that can perform basic medical tasks.

Beyond Imagination, an AI company based out of Colorado Springs, visited the Lafayette hospice center to test out the robot, named BEOMNI.

“We are excited that TRU sees the almost limitless potential of our humanoid robots in health care and has agreed to run this first pilot study with us. We look forward to partnering with them to bring a highly effective solution to market,” said inventor and CEO Dr. Harry Kloor.